A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5517 (2006.01) A61K 31/00 (2006.01) A61K 31/341 (2006.01) A61K 31/4178 (2006.01) A61K 31/4453 (2006.01) A61K 31/452 (2006.01) A61K 31/551 (2006.01) A61P 27/10 (2006.01) A61K 31/5513 (2006.01) A61K 31/221 (2006.01) A61K 31/27 (2006.01) A61K 31/695 (2006.01)
Patent
CA 2339093
A method for increasing or decreasing parasympathetic/cholinergic/ciliary tonic contraction in order to restore the resting portion of the eye and allow normal positive and negative accommodation includes administering to a presbyopic subject an effective amount of a muscarinic agent.
L'invention concerne un procédé permettant d'augmenter ou de diminuer la contraction tonique parasympathique/cholinergique/ciliaire afin de restaurer la partie de repos de l'oeil et de permettre une accommodation positive ou négative, le procédé comportant l'administration à un sujet presbyte d'une quantité efficace d'un agent muscarinique.
Gwon Arlene
Woldemussie Elizabeth
Allergan Inc.
Allergan Sales Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Cholinergic agents in the treatment of presbyopia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholinergic agents in the treatment of presbyopia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholinergic agents in the treatment of presbyopia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1505371